SC
IBB icon

Savant Capital’s iShares Biotechnology ETF IBB Stock Holding History

Savant Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
+3,345
New +$575K ﹤0.01% 1090
2025
Q1 		– Sell
-2,374
Closed -$314K – 1243
2024
Q4 		$314K Sell
2,374
-175
-7% -$24.6K ﹤0.01% 1090
2024
Q3 		$371K Sell
2,549
-315
-11% -$45.6K ﹤0.01% 1002
2024
Q2 		$393K Sell
2,864
-259
-8% -$34.6K ﹤0.01% 881
2024
Q1 		$428K Sell
3,123
-584
-16% -$79.8K ﹤0.01% 784
2023
Q4 		$504K Sell
3,707
-674
-15% -$82.2K 0.01% 561
2023
Q3 		$536K Buy
4,381
+319
+8% +$40.6K 0.01% 509
2023
Q2 		$516K Buy
4,062
+114
+3% +$14.8K 0.01% 499
2023
Q1 		$510K Buy
+3,948
New +$517K 0.01% 459
2018
Q4 		– Sell
-1,686
Closed -$206K – 278
2018
Q3 		$206K Buy
+1,686
New +$199K 0.04% 285

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Savant Capital's IBB Position: Q2 2026 in Review

Savant Capital opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 3,345 shares worth $636K. The stake represents ﹤0.01% of the portfolio and ranks #1090 among its holdings. This is a return to the name: Savant Capital previously reported a position in IBB as recently as Q4 2024.

Savant Capital first reported a position in IBB in Q3 2018 and has held it in 10 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Savant Capital held 3,345 shares of iShares Biotechnology ETF worth $636K as of Q2 2026.
  • iShares Biotechnology ETF was a new Savant Capital position in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1090 holding.
  • Savant Capital first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 10 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.